J.H. Whitney Equity Partners V Sells 47,039 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 47,039 shares of the business’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $5.72, for a total value of $269,063.08. Following the transaction, the insider now owns 1,447,191 shares of the company’s stock, valued at $8,277,932.52. This trade represents a 3.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Tuesday, April 1st, J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.63, for a total transaction of $31,415.40.
• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.63, for a total value of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH opened at $6.00 on Friday. The stock has a market capitalization of $1.17 billion, a P/E ratio of -17.65 and a beta of 2.01. The business has a 50-day moving average of $5.00 and a two-hundred day moving average of $4.91. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $6.19.

Analysts Set New Price Targets

Several brokerages have recently commented on AVAH. UBS Group upped their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a report on Friday, May 9th. Truist Financial dropped their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research note on Friday, April 11th.

Institutional Trading of Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. grew its position in shares of Aveanna Healthcare by 266.4% in the third quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company’s stock valued at $446,000 after purchasing an additional 62,319 shares during the last quarter. Barclays PLC lifted its position in Aveanna Healthcare by 80.1% in the third quarter. Barclays PLC now owns 122,689 shares of the company’s stock worth $637,000 after purchasing an additional 54,557 shares during the period. Rhumbline Advisers boosted its position in shares of Aveanna Healthcare by 11.1% during the 4th quarter. Rhumbline Advisers now owns 72,663 shares of the company’s stock valued at $332,000 after acquiring an additional 7,257 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Aveanna Healthcare by 577.0% in the 4th quarter. Legal & General Group Plc now owns 36,409 shares of the company’s stock valued at $166,000 after purchasing an additional 31,031 shares during the period. Finally, Arizona State Retirement System bought a new stake in Aveanna Healthcare in the fourth quarter valued at $64,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.